Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / A•••••• T••••••••• I•••

A•••••• T••••••••• I•••

Stage unknownCambridge, MABiotechnology
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Nov 22, 2024
    Form D equity offering · $0 (form d sold)
    Fact SEC EDGAR Form D data sets (quarterly) · “A•••••• T••••••••• I••• filed Form D: no sales yet of $200,000,000, Biotechnology”
  2. May 17, 2024
    Form D equity offering · $18.9M (form d sold) · 18 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “A•••••• T••••••••• I••• filed Form D: $18,899,969 sold of $27,700,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
5 officers, 7 directors
Timeline
3
  1. Jan 13, 2025
    A•••••• T••••••••• I••• filed Form D/A: $74,999,940 sold of $207,499,882, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Nov 22, 2024
    A•••••• T••••••••• I••• filed Form D: no sales yet of $200,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. May 31, 2024
    A•••••• T••••••••• I••• filed Form D: $18,899,969 sold of $27,700,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
42 observations
Every observation on this company